Jonathan Copp: h-index, Total Citations, and Citation Map
Jonathan Copp's h-index is 15 (15 i10-index, 4,138+ total citations across 42+ publications) according to Google Scholar as of May 2026. Jonathan Copp is affiliated with UCSD School of Medicine, UC Davis.
Jonathan Copp is a researcher affiliated with UCSD School of Medicine, UC Davis, specializing in orthopedics, nanomedicine, nanotechnology. Their work has been cited 4,138 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Jonathan Copp's Citation Metrics
Bibliometric impact based on 42 indexed publications.
- H-Index
- 15
- i10-Index
- 15
- Total Citations
- 4,138
- Citing Countries
- 18
As of May 2026.
Jonathan Copp has an h-index of 15 and 4,138 total citations across 42 publications, with research cited by institutions in 18 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Jonathan Copp's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery
20141,606
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher pioneered the use of cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery, establishing a foundational approach in biomimetic nanomedicine.
The researcher developed a folate-targeted nanoparticle delivery system for combined chemo- and radiotherapeutics to treat ovarian cancer peritoneal metastasis, establishing a novel targeted treatment approach.
The researcher developed a biomimetic nanosponge technology to absorb pore-forming toxins, a seminal contribution evidenced by a highly cited 2013 paper.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
